Phase-III efficacy trial on pain drug combo positive: Alpharma
Saturday, September 13, 2008 15:00 IST Bridgewater, New Jersey
Alpharma Inc, a global specialty pharmaceutical company, announced results from its phase-III pivotal efficacy trial that showed ALO-01 (EMBEDAä) (morphine sulfate extended-release with sequestered naltrexone